AVTR
NYSE · Life Sciences Tools & Services
Avantor Inc
$9.35
-0.23 (-2.40%)
Financial Highlights (FY 2026)
Revenue
6.57B
Net Income
-531,866,429
Gross Margin
32.6%
Profit Margin
-8.1%
Rev Growth
-4.5%
D/E Ratio
0.71
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 32.6% | 32.6% | 35.9% | 35.9% |
| Operating Margin | -3.8% | -3.4% | 11.3% | 12.6% |
| Profit Margin | -8.1% | -7.7% | 8.1% | 7.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 6.57B | 6.88B | 4.75B | 3.52B |
| Gross Profit | 2.15B | 2.25B | 1.70B | 1.26B |
| Operating Income | -251,744,144 | -237,146,461 | 534.96M | 445.57M |
| Net Income | -531,866,429 | -501,025,524 | 383.77M | 271.46M |
| Gross Margin | 32.6% | 32.6% | 35.9% | 35.9% |
| Operating Margin | -3.8% | -3.4% | 11.3% | 12.6% |
| Profit Margin | -8.1% | -7.7% | 8.1% | 7.7% |
| Rev Growth | -4.5% | -4.5% | +1.6% | -9.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.36B | 1.36B | 1.48B | 1.29B |
| Total Equity | 1.91B | 1.91B | 2.97B | 3.21B |
| D/E Ratio | 0.71 | 0.71 | 0.50 | 0.40 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -244,085,043 | -242,705,454 | 752.65M | 628.44M |
| Free Cash Flow | — | — | 295.43M | 210.66M |